EARNEST Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-82
| Closed | -$21.1K | – | 381 |
|
2023
Q3 | $21.1K | Hold |
82
| – | – | ﹤0.01% | 488 |
|
2023
Q2 | $23.4K | Hold |
82
| – | – | ﹤0.01% | 455 |
|
2023
Q1 | $22.8K | Hold |
82
| – | – | ﹤0.01% | 457 |
|
2022
Q4 | $22.7K | Hold |
82
| – | – | ﹤0.01% | 460 |
|
2022
Q3 | $22K | Hold |
82
| – | – | ﹤0.01% | 429 |
|
2022
Q2 | $17K | Hold |
82
| – | – | ﹤0.01% | 488 |
|
2022
Q1 | $17K | Hold |
82
| – | – | ﹤0.01% | 523 |
|
2021
Q4 | $20K | Hold |
82
| – | – | ﹤0.01% | 499 |
|
2021
Q3 | $23K | Hold |
82
| – | – | ﹤0.01% | 444 |
|
2021
Q2 | $28K | Hold |
82
| – | – | ﹤0.01% | 412 |
|
2021
Q1 | $23K | Hold |
82
| – | – | ﹤0.01% | 434 |
|
2020
Q4 | $20K | Hold |
82
| – | – | ﹤0.01% | 443 |
|
2020
Q3 | $23K | Hold |
82
| – | – | ﹤0.01% | 386 |
|
2020
Q2 | $22K | Sell |
82
-20
| -20% | -$5.37K | ﹤0.01% | 380 |
|
2020
Q1 | $32K | Hold |
102
| – | – | ﹤0.01% | 323 |
|
2019
Q4 | $30K | Hold |
102
| – | – | ﹤0.01% | 376 |
|
2019
Q3 | $24K | Hold |
102
| – | – | ﹤0.01% | 404 |
|
2019
Q2 | $24K | Hold |
102
| – | – | ﹤0.01% | 412 |
|
2019
Q1 | $24K | Hold |
102
| – | – | ﹤0.01% | 404 |
|
2018
Q4 | $31K | Hold |
102
| – | – | ﹤0.01% | 355 |
|
2018
Q3 | $36K | Hold |
102
| – | – | ﹤0.01% | 348 |
|
2018
Q2 | $30K | Hold |
102
| – | – | ﹤0.01% | 363 |
|
2018
Q1 | $28K | Hold |
102
| – | – | ﹤0.01% | 370 |
|
2017
Q4 | $32K | Buy |
+102
| New | +$32K | ﹤0.01% | 347 |
|
2017
Q1 | – | Sell |
-102
| Closed | -$29K | – | 322 |
|
2016
Q4 | $29K | Buy |
+102
| New | +$29K | ﹤0.01% | 341 |
|